Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する実験動画

使い捨てシリンジ

D Baum, H Ellis

    Lancet (London, England)
    |July 7, 1973
    PubMed
    まとめ

    No abstract available in PubMed .

    関連する実験動画

    関連する概念動画

    こちらも読む

    関連記事

    共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

    並び替え
    Same author

    Mechanisms of clinical resistance to selective FGFR2 inhibition by lirafugratinib.

    Annals of oncology : official journal of the European Society for Medical Oncology·2026
    Same author

    Genomic landscape of clinically acquired resistance alterations in patients treated with KRAS<sup>G12C</sup> inhibitors.

    Annals of oncology : official journal of the European Society for Medical Oncology·2025
    Same author

    Blobby is a synaptic active zone assembly protein required for memory in Drosophila.

    Nature communications·2025
    Same author

    Introducing heart rate variability technology into the UK defence mild traumatic brain injury service.

    BMJ military health·2022
    Same author

    Review of neurological rehabilitation for Multiple Sclerosis in the British Military.

    BMJ military health·2021
    Same author

    Unexpected difficult tracheal intubation secondary to subglottic stenosis leading to emergency front-of-neck airway.

    Anaesthesia reports·2021
    Same journal

    Assisted dying and the silencing of medicine's next generation.

    Lancet (London, England)·2026
    Same journal

    Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

    Lancet (London, England)·2026
    Same journal

    Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

    Lancet (London, England)·2026
    Same journal

    [<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

    Lancet (London, England)·2026
    Same journal

    Research priorities for characterising Bundibugyo virus.

    Lancet (London, England)·2026
    Same journal

    Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

    Lancet (London, England)·2026
    関連記事をすべて見る